Financial statements Adpharma

Cash flow statement of Adpharma

Company age:
Age:
19 y. 6 m. 19 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Cash flow Profitability

Cash inflows of ADPHARMA

Year
2023
Net cash from operating expenses -3 453 882,37
Net cash flow from investing activities -15 754,44
Net cash flow from financial activities 4 184 387,08
Total net cash flow 714 750,27
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.